Perrigo's stock tumbles 14% after sales miss and lowered guidance
Perrigo Co. Plc's stock (PRGO) fell 14% early Tuesday, after the consumer self-care and wellness products maker posted weaker-than-expected third-quarter sales and lowered its guidance. Dublin, Ireland-based Perrigo had net income of $14.2 million, or 10 cents a share, for the quarter, after a loss of $49.4 million, or 37 cents a share, in the year-earlier period. Adjusted per-share earnings came to 64 cents, ahead of the 63 cent FactSet consensus. Sales rose 2.2% to $1.1 billion, just below the $1.2 billion FactSet consensus. The company is now expecting full-year adjusted EPS of $2.50 to $2.60, down from prior guidance of $2.50 to $2.70. It expects sales to grow 4% to 6%, down from prior guidance of 7% to 11%. The stock has fallen 16% in the year to date, while the S&P 500 has gained 13.7%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-07-23 0651ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations